Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.
Circulation. 2009 Jan 27;119(3):417-25. doi: 10.1161/CIRCULATIONAHA.107.750745. Epub 2009 Jan 12.
Circulation. 2009.
PMID: 19139391
Clinical Trial.
Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy.
Drummond W, Munger MA, Rafique Essop M, Maboudian M, Khan M, Keefe DL.
Drummond W, et al. Among authors: maboudian m.
J Clin Hypertens (Greenwich). 2007 Oct;9(10):742-50. doi: 10.1111/j.1524-6175.2007.06614.x.
J Clin Hypertens (Greenwich). 2007.
PMID: 17917501
Free PMC article.
Clinical Trial.
Item in Clipboard
A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
Vaidyanathan S, Maboudian M, Warren V, Yeh CM, Dieterich HA, Howard D, Dole WP.
Vaidyanathan S, et al. Among authors: maboudian m.
Curr Med Res Opin. 2008 Aug;24(8):2313-26. doi: 10.1185/03007990802259354.
Curr Med Res Opin. 2008.
PMID: 18786303
Item in Clipboard
Aliskiren exhibits similar pharmacokinetics in healthy volunteers and patients with type 2 diabetes mellitus.
Zhao C, Vaidyanathan S, Yeh CM, Maboudian M, Armin Dieterich H.
Zhao C, et al. Among authors: maboudian m.
Clin Pharmacokinet. 2006;45(11):1125-34. doi: 10.2165/00003088-200645110-00006.
Clin Pharmacokinet. 2006.
PMID: 17048976
Clinical Trial.
Item in Clipboard
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial.
Scirica BM, Morrow DA, Bode C, Ruzyllo W, Ruda M, Oude Ophuis AJ, Lopez-Sendon J, Swedberg K, Ogorek M, Rifai N, Lukashevich V, Maboudian M, Cannon CP, McCabe CH, Braunwald E.
Scirica BM, et al. Among authors: maboudian m.
Eur Heart J. 2010 Aug;31(16):1993-2005. doi: 10.1093/eurheartj/ehq190. Epub 2010 Jun 17.
Eur Heart J. 2010.
PMID: 20558431
Clinical Trial.
Item in Clipboard
Dose-proportional pharmacokinetics of d-threo-methylphenidate after a repeated-action release dosage form.
Tuerck D, Appel-Dingemanse S, Maboudian M, Pommier F, Wang Y, Sedek G.
Tuerck D, et al. Among authors: maboudian m.
J Clin Pharmacol. 2007 Jan;47(1):64-9. doi: 10.1177/0091270006293757.
J Clin Pharmacol. 2007.
PMID: 17192503
Clinical Trial.
Item in Clipboard
Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man.
Tuerck D, Wang Y, Maboudian M, Wang Y, Sedek G, Pommier F, Appel-Dingemanse S.
Tuerck D, et al. Among authors: maboudian m.
Int J Clin Pharmacol Ther. 2007 Dec;45(12):662-8. doi: 10.5414/cpp45662.
Int J Clin Pharmacol Ther. 2007.
PMID: 18184535
Clinical Trial.
Item in Clipboard
Cite
Cite